Medindia

X

Gene Variant That Worsens Survival Chances for Breast Cancer Patients Identified

by VR Sreeraman on  May 31, 2008 at 12:40 PM Cancer News   - G J E 4
European doctors said Friday they had identified a genetic characteristic that strongly worsens survival chances for women with breast cancer who are treated with a common form of chemotherapy.
 Gene Variant That Worsens Survival Chances for Breast Cancer Patients Identified
Gene Variant That Worsens Survival Chances for Breast Cancer Patients Identified
Advertisement

The telltale sign is a variant of a gene called NQO1, which in its normal form produces an enzyme that protects cells against oxidative stress -- a key factor in the spread of cancer.

Advertisement
The variant of NQ01, called NQ01*2, stops production of this protective enzyme. It is present in between four and 20 percent of the world's population, with a preponderance in Asia, according to figures presented in the study.

The researchers -- led by Heli Nevanlinna of the University of Helsinki and Jiri Bartek, a Czech scientist with the Danish Cancer Society -- found that women who had a double copy of NQ01*2 in their genome had only a 17-percent survival rate when treated with an anthracyclin-based chemotherapy.

Those who had only a single copy of NQ01*2, or did not have the variant at all, had a survival rate of 75 percent.

The paper, published online by the specialised British journal Nature Genetics, is based on DNA data from more than 2,000 Finnish women treated for breast cancer.

Source: AFP
SRM
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All